Skip to content

The dramatic race to discover Insulin

Throughline

37m
Transcript

Original podcast

Where to listen

Summary

Written by a model from the transcript; not yet reviewed.

This episode explores the dramatic and fraught discovery of insulin in the early 1920s, tracing how a struggling Canadian surgeon named Fred Banting conceived the idea in a middle-of-the-night fever dream. Alongside graduate student Charlie Best, and later biochemist James Bertram Collip under the supervision of physiologist J.J.R. MacLeod, Banting raced against time to extract and purify pancreatic secretions that could save diabetes patients from certain death. Despite severe personal conflicts, frantic animal testing, and experimental injections of crude brown sludge, the team successfully treated a dying 14-year-old boy named Leonard Thompson in Toronto.

The narrative highlights the chaotic, high-stakes human elements behind one of modern medicine's greatest breakthroughs, including messy lab conditions, near-constant professional squabbling, and the decision by the inventors to sell their patent to the University of Toronto for just one dollar to ensure global accessibility. Ultimately, the discovery transformed a fatal diagnosis into a manageable condition, saving millions of lives while leaving a complex legacy of shared credit, oversight, and enduring gratitude from patients around the world.

  • Before the discovery of insulin, individuals diagnosed with diabetes faced a strict starvation diet that extended their life by only a few years at most. 10:47
  • Fred Banting conceived his breakthrough extraction idea by writing down 25 words after waking up abruptly from a restless sleep at 2:00 a.m. 11:30
  • The inventors sold their insulin patent to the University of Toronto for one dollar each to make the treatment widely available and prevent monopolies. 34:43
  • Following the 1923 Nobel Prize announcement, Fred Banting split his prize money with Charlie Best, and MacLeod shared his with James Colip. 36:27

Chapters

  1. 0:00
    Introduction and Context

    The host sets the stage, introducing the story of insulin and its impact on diabetes care.

  2. 5:53
    The Birth of a Hypothesis

    Fred Banting conceives the idea of extracting pancreatic secretions to treat diabetes after reading a journal article.

  3. 13:09
    Seeking Support at U of T

    Banting approaches J.J.R. MacLeod for laboratory space and funding, initially facing skepticism but eventually gaining approval.

  4. 18:42
    Dog Experiments and Early Success

    Banting and student Charlie Best conduct experiments on dogs, achieving a breakthrough in lowering blood glucose.

  5. 27:38
    First Human Trial

    The team injects Leonard Thompson with a refined insulin extract, marking the first successful treatment of a human patient.

  6. 34:16
    Scaling Production and Patent Strategy

    The discovery is patented, production is scaled, and the team partners with Eli Lilly to meet growing demand.

  7. 35:45
    Nobel Recognition and Internal Tensions

    Banting, Best, MacLeod, and Colip receive the Nobel Prize, sparking disputes over credit and prize money distribution.

  8. 40:00
    Legacy and Impact

    The episode reflects on insulin’s lasting influence, the personal stories of those involved, and the enduring gratitude from patients worldwide.

Highlights

  • 0:19

    Grim Reality of Diabetesstory

    Leonard Thompson checks into Toronto General Hospital weighing only 65 pounds, suffering from severe starvation and near death while enduring a strict 450-calorie diet.

  • 5:42

    Fred Banting's Early Strugglesstory

    Before discovering insulin, Fred Banting struggled academically, failed his first year of university, and went nearly a month without a single patient at his new medical practice.

  • 11:23

    The 25-Word Middle-of-the-Night Ideainsight

    Waking up at 2:00 a.m. after reading an article on diabetes research, Banting scribbled down a 25-word hypothesis involving ligating pancreatic ducts of dogs to isolate internal secretions.

  • 13:26

    Pitching a Noted Physiologistdebate

    Banting traveled to the University of Toronto to pitch his sparse 25-word idea to renowned physiologist J.J.R. MacLeod, who viewed the rookie surgeon with understandable skepticism.

  • 18:30

    Capturing Dogs in Alleysstory

    Banting and graduate student Charlie Best ran through the streets of Toronto rounding up stray dogs using makeshift leashes to remove their pancreases and induce diabetes for testing.

  • 20:31

    First Successful Animal Testdata

    On July 30th, 1921, an extract from a dog's pancreas was injected into a terrier named 410, successfully lowering its blood glucose levels for a day before the animal succumbed.

  • 25:28

    Colip's Purified Extractstrategy

    After Banting's initial trial failed, biochemist James Colip refined the purification process using adjusted levels of alcohol to create a clear extract that successfully revived Leonard Thompson.

  • 26:06

    Treating Leonard Thompsonstory

    Without consulting colleague James Colip, Banting and Best administered a thick brown pancreatic extract to a dying Leonard Thompson, which resulted in sterile abscesses and no clinical benefit.

Quotes

  • “The first patient who was successfully treated with insulin.”
    Unnamed speaker · 30:27
  • “They had successfully extracted pancreatic cells and added them to a solution that seemed to work.”
    Unnamed speaker · 21:19
  • “The men can continue their work. He isn't about to pat Banting on the back, but he can see they were on to something, maybe something big.”
    Unnamed speaker · 22:46
  • “The patent was taken out in the names of Banting, Best, and Colip. And what they did was they sold the patent to the University of Toronto for $1.”
    Unnamed speaker · 34:43
  • “The whole idea was that they wanted to make insulin available at a low cost to everyone who needed it around the world.”
    Unnamed speaker · 35:17
  • Midi Health 0:00–0:15
  • Superhuman 4:06–4:31
  • Capella University 4:32–4:44
  • Bowlin Branch 4:47–5:39
  • Southern Environmental Law Center 5:15–5:39
  • Capella University 31:10–31:22
  • Bowlin Branch 31:25–31:50
  • Southern Environmental Law Center 31:53–32:17
  • Bowlin Branch 41:30–41:55
  • Whole Foods Market 41:59–42:23

About this episode

Looksmaxxing, weight loss, and muscle building have fueled a massive craze for injectable peptides. Some natural and some synthetic. These injectables have unleashed a multi-billion-dollar gray-market industry online and a high-stakes frontier for the pharmaceutical industry. Today, we reach back to the quest to manufacture the first peptide-based medicine: Insulin. Guests: Alison Li, historian of science and medicine, author of J. B. Collip and the Development of Medical Research in Canada: Extracts and Enterprise Grant Maltman, curator of Banting House National Historic Site Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org http://plus.npr.org/. See pcm.adswizz.com https://pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. NPR Privacy Policy https://www.npr.org/about-npr/179878450/privacy-policy

Transcript

0:00
37:08

6,039 words · 7 speakers

Topics

  • Toronto
  • Insulin
  • University of Toronto
  • Ontario
  • Canada
  • Toronto General Hospital
  • Bunsen burner
  • Eli Lilly
  • London, Ontario
  • GLP-1 drugs

Page updated · transcript and summary are machine-generated